When: Confirmed close >$456 on volume >3M shares with RSI>70

Then: Pre-committed sizing reassessment upward — not reactive addition

When: Daily close below $431 (10 EMA) on two consecutive sessions

Then: Exit position — stop-loss mechanism activated

HOLD at current levels; do not chase at 440; maintain trailing stop at 10 EMA; wait for pullback to 414-431 zone to add

• Entry at 440 is unfavorable given two-week overbought RSI without mean reversion; historical price strength does not prevent future corrections
• Risk/reward framing is misleading: aggressive analyst's 1:12 ratio ignores 58 dollar risk to 50 SMA at 382 and 90 dollar risk to 200 SMA at 350
• AMGN at 98 percent of 52-week range with lower-high formation at 447; macro tailwinds do not justify tactical entry at highs
• Beta of 0.41 does not protect against absolute drawdowns; 57 billion in debt creates vulnerability to 15-20 percent correction on narrative shift
• TScan termination signals management capital allocation decisions worth monitoring as soft risk indicator
• Better risk-adjusted opportunities exist: short-duration Treasuries yielding 4+ percent, IG corporates at 5+ percent, dividend aristocrats 15-20 percent off highs

→ vs aggressive: Argues the 1:12 risk/reward is mathematically misleading because the 112 dollar upside is in the rearview mirror; actual forward risk includes 58 dollars to 50 SMA and 90 dollars to 200 SMA

→ vs aggressive: Beta 0.41 does not protect against absolute drawdowns; AMGN has 57 billion in debt and can correct 15-20 percent in a quarter while the market is flat

→ vs aggressive: Macro tailwinds justify holding but not tactical entry at 52-week highs; disciplined entry requires pullback regardless of macro backdrop

→ vs aggressive: Opportunity cost argument is dishonest; short-duration Treasuries at 4 percent and IG corporates at 5 percent offer better risk-adjusted returns without concentration risk

→ vs aggressive: Two weeks of elevated RSI proves trend has been powerful, not that mean reversion cannot occur; conflating recent price action with forward probability is recency bias

HOLD with neutral weight; trailing stop at 10 EMA (431); scale-in trigger at 414-431 with RSI reset below 60 and volume capitulation or bullish reversal; breakout reassessment trigger above 456 on above-average volume with RSI above 70; hard exit trigger on 10 EMA break with RSI failure below 65.

• MACD histogram expanding from 1.10 to 1.49 confirms real momentum
• Risk-to-reward at 440 entry is closer to 1:2, not the claimed 1:12, when accounting for 9-dollar risk to 10 EMA stop versus 16-dollar target to upper Bollinger at 456
• RSI printing 79.80 indicates overbought condition at 98 percent of 52-week range
• Beta 0.41 does not protect against AMGN-specific idiosyncratic risks including patent cliff, IRA expansion, or clinical readouts
• Structural downside risk extends to 50 SMA at 382 (58 dollars away) or 200 SMA at 350 (90 dollars away)
• Existing plan is well-aligned with this framework; only refinement needed is formalizing breakout trigger conditions in writing
• Opportunity cost argument is valid: 4 percent risk-free in Treasuries and dividend aristocrats off 52-week highs are real alternatives

→ vs aggressive: Risk-to-reward framing of 1:12 is misleading; using realized upside as available to fresh buyers is incorrect; actual risk-reward is closer to 1:2 at best

→ vs aggressive: Overweight sizing at 98 percent of 52-week range with RSI at 79.80 is textbook mistake at cycle highs; momentum does not immunize position from entry risk

→ vs aggressive: Beta 0.41 argument is a category error; low-beta names can experience 15-20 percent drawdowns on idiosyncratic catalysts while S&P is flat

→ vs aggressive: Opportunity cost argument assumes AMGN is best risk-adjusted opportunity available, which is an unprovable claim when alternatives exist

→ vs conservative: Pullback to 414-431 is not inevitable; treating it as such is its own form of recency bias; MACD expansion signals next leg could extend before pullback materializes

→ vs conservative: 2008 subprime comparison for a Crohn's research collaboration wind-down is hyperbole that undermines credibility on otherwise valid soft-signal point

→ vs conservative: Dismissing breakout above 456 as 'we'll reassess then' means missing the move entirely if momentum continues

→ vs conservative: Opportunity cost counter is strongest part of conservative case; AMGN being uniquely attractive claim is empirically wrong